Specifically, LAT1 has been identified as an independent prognostic factor in various cancers, including primary liver cancer, and is associated with increased tumor growth via the mammalian target of rapamycin signaling pathway [36, 38, 40, 41]. The gene discussed is MTOR; the disease is liver cancer.